Stephen Williamson
8PUBLICATIONS
47CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 18, 2024
First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced Malignancies.Nehal J Lakhani, Kyriakos P Papadopoulos, Melissa Lynne Johnson
|Feb 20, 2024
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort.Anwaar Saeed, Robin Park, Harsh Pathak
|Jun 10, 2023
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma.Nataliya Mar, Yousef Zakharia, Alejandro Falcon
|May 13, 2023
A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors.Gary Edward Richardson, Raed Al-Rajabi, Dipesh Uprety
|Feb 19, 2021
Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer.Priyanka Sharma, Vandana G Abramson, Anne O'Dea
|Oct 17, 2020
Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer.Jessica Allen, Colin Cernik, Suhaib Bajwa
Pageof 2
Frequent Collaborators
2 joint publications
Andrew K Godwin
2 joint publications
Joaquina Baranda
1 joint publications
Vandana G Abramson
1 joint publications
Lauren Nye
1 joint publications
Milind A Phadnis
1 joint publications
Bruce F Kimler
1 joint publications
Hirva Mamdani
1 joint publications
Nitika
1 joint publications
Yousef Zakharia
1 joint publications
Rafael Morales-Barrera
